Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 22540280)

Published in J Eur Acad Dermatol Venereol on April 28, 2012

Authors

T Maier1, M Braun-Falco, T Hinz, M H Schmid-Wendtner, T Ruzicka, C Berking

Author Affiliations

1: Department of Dermatology and Allergology, Ludwig-Maximilian University of Munich, Munich, Germany. tanja.maier@med.uni-muenchen.de

Articles citing this

In Vivo Multiphoton Microscopy of Basal Cell Carcinoma. JAMA Dermatol (2015) 1.62

Optical techniques for the noninvasive diagnosis of skin cancer. J Cancer Res Clin Oncol (2013) 0.88

Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy. Photonics Lasers Med (2013) 0.84

Evaluation of Optical Coherence Tomography as a Means of Identifying Earlier Stage Basal Cell Carcinomas while Reducing the Use of Diagnostic Biopsy. J Clin Aesthet Dermatol (2015) 0.80

In Vivo Noninvasive Imaging of Healthy Lower Lip Mucosa: A Correlation Study between High-Definition Optical Coherence Tomography, Reflectance Confocal Microscopy, and Histology. Dermatol Res Pract (2013) 0.79

Recent advances in clinical application of optical coherence tomography of human skin. Clin Cosmet Investig Dermatol (2015) 0.78

Noninvasive characterisation of foot reflexology areas by swept source-optical coherence tomography in patients with low back pain. Evid Based Complement Alternat Med (2013) 0.77

Imaging Blood Vessel Morphology in Skin: Dynamic Optical Coherence Tomography as a Novel Potential Diagnostic Tool in Dermatology. Dermatol Ther (Heidelb) (2017) 0.77

In vivo assessment of optical properties of basal cell carcinoma and differentiation of BCC subtypes by high-definition optical coherence tomography. Biomed Opt Express (2016) 0.75

Noninvasive real-time characterization of non-melanoma skin cancers with handheld optoacoustic probes. Photoacoustics (2017) 0.75

The Use of Noninvasive Optical Coherence Tomography to Monitor the Treatment Progress of Vismodegib and Imiquimod 5% Cream in a Transplant Patient with Advanced Basal Cell Carcinoma of the Nose. J Clin Aesthet Dermatol (2016) 0.75

A novel imaging approach to periocular basal cell carcinoma: in vivo optical coherence tomography and histological correlates. Eye (Lond) (2015) 0.75

[Modern diagnostic procedures in dermatological oncology]. Pathologe (2015) 0.75

Articles by these authors

CPF1, a yeast protein which functions in centromeres and promoters. EMBO J (1990) 3.65

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70

Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol (2012) 2.67

Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol (2000) 2.66

Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1998) 2.41

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today (1998) 2.19

Lupus erythematosus tumidus--a neglected subset of cutaneous Lupus erythematosus: report of 40 cases. Arch Dermatol (2000) 2.09

High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol (1997) 1.96

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95

Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol (2005) 1.90

Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75

Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1997) 1.73

Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol (2014) 1.73

Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet (1994) 1.64

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma. Ann Oncol (2014) 1.63

Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease. Br J Dermatol (2010) 1.63

Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol (2009) 1.60

Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol (1999) 1.59

Novel Hairless mutations in two kindreds with autosomal recessive papular atrichia. J Invest Dermatol (1999) 1.58

Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection. J Eur Acad Dermatol Venereol (2008) 1.52

Acquired syphilis II in early childhood: reappearance of syphilis brephotrophica. J Am Acad Dermatol (1998) 1.49

Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma. Dermatology (1995) 1.46

[Sudden greying or whitening of the scalp hair]. Dtsch Med Wochenschr (1995) 1.45

A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet (2004) 1.45

Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43

Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest (2000) 1.42

Red lunulae in severe alopecia areata. Acta Derm Venereol (1992) 1.42

Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet (1998) 1.41

Papular-purpuric 'gloves and socks' syndrome associated with human herpesvirus 6 infection. Arch Dermatol (1998) 1.40

The hand eczema proteome: imbalance of epidermal barrier proteins. Br J Dermatol (2015) 1.40

Efficacy and skin tolerability of Saliker in the treatment of dandruff. Eur J Dermatol (2002) 1.40

Persistent granulomatous plaque type zoster in a patient with HIV infection. Int J Dermatol (2011) 1.38

[The differential diagnosis of nodular tumors of the hand]. Dtsch Med Wochenschr (1994) 1.38

Assessing the effectiveness of Dead Sea products. Isr Med Assoc J (2007) 1.37

Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35

Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol (2000) 1.32

Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem (1999) 1.31

Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci U S A (2000) 1.28

Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol (2009) 1.26

Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene. Cancer Res (2000) 1.25

Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol (2005) 1.24

Angiolymphoid hyperplasia with eosinophilia treated with anti-interleukin-5 antibody (mepolizumab). Br J Dermatol (2004) 1.23

Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol (2001) 1.20

Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol (2011) 1.18

Congenital erythropoietic porphyria. J Am Acad Dermatol (1997) 1.17

FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients. Br J Cancer (2006) 1.16

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol (2002) 1.15

Arylhydrocarbon hydroxylase activity in lymphocytes of patients with psoriasis. Lancet (1980) 1.14

Nitric oxide in human skin: current status and future prospects. J Invest Dermatol (1998) 1.13

Regulatory requirements for clinical trial and marketing authorisation application for cell-based medicinal products. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2010) 1.07

Type 1 segmental cutaneous leiomyomatosis. Clin Exp Dermatol (2002) 1.07

Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53. Cell Death Differ (2006) 1.06

Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett (1992) 1.05

Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol (2012) 1.05

Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol (1986) 1.04

Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene? Hum Genet (1996) 1.04

Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol (2010) 1.04

Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol (1998) 1.04

A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med (1996) 1.04

Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. J Invest Dermatol (1983) 1.02

Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med (1997) 1.02

Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol (1993) 1.02

Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma. J Cutan Pathol (2007) 1.02

Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum (2007) 1.01

Dapsone in the treatment of lupus erythematosus. Br J Dermatol (1981) 0.99

Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J Invest Dermatol (1998) 0.99

Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol (1998) 0.99

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy (2008) 0.99

Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes. J Immunol (1997) 0.99

Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol (1998) 0.99

Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. Melanoma Res (2000) 0.98

Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatr Dermatol (1997) 0.98

Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol (1995) 0.97

MSH6 mutation in Muir-Torre syndrome: could this be a rare finding? Br J Dermatol (2007) 0.96

Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch (2000) 0.96

An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol (2009) 0.96

Defects of mitochondrial respiratory chain in multiple symmetric lipomatosis. Arch Dermatol Res (1998) 0.96

Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence. J Cell Sci (1998) 0.94

Pyoderma gangrenosum after cesarean delivery. Am J Obstet Gynecol (2000) 0.94

Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol (2000) 0.94

Plantar malignant melanoma -- a challenge for early recognition. Melanoma Res (2000) 0.94

Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol (2006) 0.93

Treatment of atopic eczema with oral alitretinoin. Br J Dermatol (2009) 0.93

Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation. Br J Dermatol (2005) 0.93

Ex vivo application of delta-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy. Photochem Photobiol (1997) 0.93

Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem Photobiol (1997) 0.93

Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol (2001) 0.93

Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol (1998) 0.93

[Erythema annulare centrifugum Darier. Successful therapy with topical calcitriol and 311 nm-ultraviolet B narrow band phototherapy]. Hautarzt (2007) 0.93

Surgical pearl: nail splinting by flexible tube--a new noninvasive treatment for ingrown toenails. J Am Acad Dermatol (1998) 0.93

Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol (2015) 0.92

Chronic cutaneous damage after accidental exposure to ionizing radiation: the Chernobyl experience. J Am Acad Dermatol (1994) 0.92

Accuracy of a smartphone application using fractal image analysis of pigmented moles compared to clinical diagnosis and histological result. J Eur Acad Dermatol Venereol (2014) 0.92